Clinical Trial

Cantargia Reports US Regulatory Approval to Start Pancreatic Cancer Phase IIb Trial with Nadunolimab

LUND, SWEDEN / ACCESSWIRE / February 20, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported that after…

11 months ago

Elligo Health Research Expands EU and U.K. Clinical Trial Support With WHYZE Health

AUSTIN, Texas--(BUSINESS WIRE)--#clinicalresearch--Elligo Health Research®, the largest healthcare-enabling research organization, today announced a new collaboration with WHYZE Health, an Ireland-based…

11 months ago

Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth

IRVINE, Calif. & DENVER--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth, a…

11 months ago

Florence Healthcare and Slope Unite Forces to Address Site Technology Ecosystem Demand

Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All…

11 months ago

Yunu Emerges as Industry Leader to Address the Way Imaging Data Impacts Breakthrough Therapy Development

Fast-growing innovator brings first-of-its-kind imaging ecosystem to clinical trialsCARY, NC / ACCESSWIRE / February 20, 2024 / With the rapid…

11 months ago

PharmAla Data to be Published in ACS Chemical Neuroscience

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research…

11 months ago

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,…

11 months ago

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science…

11 months ago

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

Amendment to existing exclusive license agreement with Orion Corporation expands Tenax’s territory rights from North America, to the entire worldExpanded…

11 months ago

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing…

11 months ago